username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies

Clicks:285 Date:09/24/13

BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization & Comparability Testing
Expands Glasgow, Scotland Testing Facilities and Ramps up Commercial Activities in US and Asia-Pacific

BOSTON, Mass., US and GLASGOW, Scotland, UK, September 23, 2013 / B3C newswire / 鈥 BioOutsource Ltd. (鈥淏ioOutsource鈥), a leading international Contract Testing Organization (CTO) has consolidated its position as the leading expert in the biological analysis of Biosimilar Monoclonal Antibodies for the biopharmaceutical industry. Strategic internal R&D investment has enabled the creation and launch of a wide range of off-the-shelf testing methodologies to support comparability, stability and lot release testing for Biosimilars. As a result the company has achieved excellent market penetration and sales growth this year and is now working in collaboration with many of the world鈥檚 leading Biosimilar companies.

"Our extensive experience in developing and validating cell-based assays and strategic R&D investment has created a niche position for us within the industry, which enables BioOutsource to provide testing solutions that can significantly reduce the time and cost of Biosimilar development programmes,鈥 commented BioOutsource CEO Gerry MacKay. 鈥淲e are continuing to invest and expand our testing capabilities in Glasgow, Scotland and are significantly increasing commercial activities in the North American and Asia-Pacific regions to support surging demand for Biosimilar characterisation & comparability testing. We are delighted to be working with more than 30 of the top Biosimilar players globally, and look forward to continued strong growth in 2014.鈥


About BioOutsource Ltd
BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry鈥檚 increasingly preferred testing partner. We understand the importance of our service to support our client鈥檚 critical testing requirements and as a result, continually strive to provide a world class service globally.

Dr. Verna McErlane
Director of Sales
BioOutsource, Ltd.
+ 44 (0) 141 946 4222


Bill Douglass
Gotham Communications, LLC

Related News>> more
  • Micronic Celebrates 30 Years in Sample Storage4/24/2014
  • INTEGRA:Marine Lab Ramps Up Microbiology Research Efforts4/24/2014
  • Exeter Analytical锛欼dentifying an Optimal Biofuel4/24/2014
  • AMSBIO Expands US Operations4/23/2014
  • OGT:Achieving high quality microarray results4/22/2014
  • EKF鈥檚 New Lactate Scout+ Analyzer Delivers Cutting-Edge Benefits in Sports Science4/17/2014
  • Titan Enterprises:Flow Meters Provide Valuable Data to Formula 1© Racing Teams4/16/2014
  • Thermo Fisher:New Peristaltic Pump Delivers Unparalleled Flexibility in Fluid Transfer4/15/2014
  • Porvair Completes Delivery of Major Hot Gas Filtration Contract4/15/2014
  • Genevac:Productive Hands Free Evaporation4/11/2014
  • advertisement

    Copyright(C) 2006-2014 bio-equip   娌狪CP澶06040519鍙